Abstract:Insulin-like growth factor 2 messenger RNA-binding proteins have been described to associate with malignant process in many cancers. However, the role of insulin-like growth factor 2 messenger RNA-binding protein family has not been thoroughly elucidated in non–small cell lung cancer. This study was to investigate the expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins family in non–small cell lung cancer. The expression levels of IGF2BP1–IGF2BP3 in tumor and adjacent normal tissues were determined, and association with clinicopathological features and overall survival was investigated by analyzing The Cancer Genome Atlas lung cancer database. Proliferation, migration, invasion assays, and flow-cytometry analysis were used to investigate the biological function in vitro. Insulin-like growth factor 2 messenger RNA-binding protein expression levels were significantly increased in non–small cell lung cancer compared to adjacent normal lung tissues. Chi-square test indicated that IGF2BP1 and IGF2BP3 expressions correlated with some meaningful clinical characteristics in non–small cell lung cancer. Kaplan–Meier analysis showed that high-level expression of IGF2BP1 or IGF2BP3 predicted poor overall survival in lung adenocarcinoma patients. Multivariate regression analysis showed that high level of IGF2BP3 was an independent risk factor for poor prognosis in lung adenocarcinoma patients (hazard ratio = 1.616, p = 0.017). In vitro, knockdown of IGF2BP3 inhibited lung adenocarcinoma cell proliferation by inducing cell cycle arrest and apoptosis, and undermined abilities of migration and invasion, and overexpression of IGF2BP3 could promote malignant phenotypes in lung adenocarcinoma cells. Our study revealed that expression of insulin-like growth factor 2 messenger RNA-binding proteins was widely upregulated and correlated with some certain clinicopathological features in non–small cell lung cancer. Especially, in insulin-like growth factor 2 messenger RNA-binding protein family, IGF2BP3 might play the most important role in tumor aggressiveness and prognosis in lung adenocarcinoma, and IGF2BP3 might serve as a potential therapeutic target and a novel prognostic biomarker in lung adenocarcinoma patients.

Clinical Significance of Insulin-like Growth Factor 1 and Insulin Like Growth Factor Binding Protein 3 in Serum of Patients with Lung Cancer

Clinical significance of insulin like growth factor binding protein 3 in patients with lung cancer

Igfbp, A Novel Target of Lung Cancer?

Expression Profile, Clinical Significance, and Biological Function of Insulin-Like Growth Factor 2 Messenger RNA-binding Proteins in Non–small Cell Lung Cancer

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

[Serum Levels of Endostatin and VEGF in Non-Small Cell Lung Cancer Patients and the Relationship with the Clinical Pathophysiological Characteristics].

Association Between Circulating Levels Of Igf-1 And Igfbp-3 And Lung Cancer Risk: A Meta-Analysis

Plasma Levels Of Insulin-Like Growth Factor-I And Lung Cancer Risk: A Case-Control Analysis

Insulin-like Growth Factor Binding Protein-2 Level is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival.

Serum levels of Sicam-1 and TNF-α and their significance in patients with lung cancer in late stage

Effect of insulin like growth factor binding protein 3 on non-small cell lung cancer

Expression of Glucose Transporter 1 and Glucose Transporter 3 in Non-small Cell Lung Cancer and Its Clinical Significance

Expression of Glucose Transporter in Non-Small Cell Lung Carcinoma and Its Clinical Significance

[Correlation of the Expression of III Β-Tubulin and MDR1 Protein with Biological Features of Non-Small Cell Lung Cancer].

The Relationships Between the Serum Levels of Β2-Mg, VEGF, Bfgf, and IL-6 in Patients with Diffuse Large B Cell Lymphoma and Parameters of International Prognostic Index

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets

[Expression and Clinical Significance of Cancer-derived Immunoglobulin G in Non-small Cell Lung Cancer by Bioinformatics and Immunohistochemistry].

EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND BASIC FIBROBLAST GROWTH FACTOR IN HUMAN NON-SMALL CELL LUNG CANCER AND THEIR CLINICAL SIGNIFICANCE

Evaluation of Serum Levels of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Patients With Colorectal Cancer: A Case-Control Study

Assessment of Insulin-Like Growth Factors and Mutagen Sensitivity As Predictors of Lung Cancer Risk.

Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer